Prevalence of microalbuminuria in recently diagnosed Type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study by Viberti, G, Freed, M, Holman, R, Lachin, J, Heise, M, Grp, A

Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study by Holman, R, Kahn, SE, Heise, M, Porter, L, Freed, M, Grp, A

Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler (R)) for the treatment of adult asthma by Stradling, JR, Pearson, MG, Morice, A, Peake, MD, Barnes, N, Grp, A

Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with AS: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for AS (ATLAS) (vol 35, pg 1346, 200... by Revicki, D, Luo, M, Wordsworth, P, Wong, R, Chen, N, Jr, D, Grp, A

Validity and reliability of the German language SF-36 health survey in patients with amyotrophic lateral sclerosis by Pongratz, D, Zierz, S, Fischer, W, Jenkinson, C, Fitzpatrick, R, Peto, V, Swash, M, Grp, A

A comparison of CT versus diffusion weighted imaging in hyperacute stroke using a systematic quantitative score (ASPECTS) by Barber, P, Hill, MD, Demchuk, A, Pexman, J, Hudon, M, Tomanek, A, Frayne, R, Buchan, A, Grp, A

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial by Hata, J, Arima, H, Rothwell, P, Woodward, M, Zoungas, S, Anderson, C, Patel, A, MacMahon, S, Chalmers, J, Grp, A

Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial. by Van der Heijde, D, Luo, M, Matsumoto, A, Mease, P, Torre-Alonso, J, Wordsworth, P, Wong, R, Davis, J, Grp, A

Changes in bone metabolism biomarkers in the ADOPT study by Kahn, SE, Herman, W, Holman, R, Haffner, S, Zinman, B, Aftring, R, Kravitz, BG, Paul, G, Jones, N, Lachin, J, Viberti, G, Grp, A

Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-... by van der Heijde, D, Dijkmans, B, Schiff, M, Kivitz, A, de Vlam, K, Wordsworth, P, Ballal, S, Kupper, H, Wong, R, Sieper, J, Grp, A

Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas by Wordsworth, P, Dijkmans, B, van der Heijde, D, Davis, J, Schiff, M, Kivitz, A, Sieper, J, Mease, P, Kupper, H, Wong, R, Grp, A

Comparison of innovative estimation of efficacy to standard using the ACCENT database by Chapman, J, O'Callaghan, C, Hu, N, Ding, K, Yothers, G, Catalano, P, Shi, Q, Gray, R, O'Connell, M, Sargent, D, Grp, A

Predictive and prognostic value of gender in early-stage colon cancer: A pooled analysis of 33,345 patients from the ACCENT database by Cheung, W, Shi, Q, O'Connell, M, Cassidy, J, Blanke, C, Kerr, D, Van Cutsem, E, Alberts, SR, Yothers, G, Sargent, J, Grp, A